Sanò, M.V.; Marino, L.; Puleo, M.; Pafumi, S.; Marletta, S.; Ricciardi, G.R.R.; Carnaghi, C.
High-Risk Node-Positive Hormone Receptor-Positive/HER2-Low Breast Cancer Relapse on Adjuvant Abemaciclib Treatment with ER Loss at Metastatic Recurrence: A Case Report and Literature Review. Diagnostics 2025, 15, 3042.
https://doi.org/10.3390/diagnostics15233042
AMA Style
Sanò MV, Marino L, Puleo M, Pafumi S, Marletta S, Ricciardi GRR, Carnaghi C.
High-Risk Node-Positive Hormone Receptor-Positive/HER2-Low Breast Cancer Relapse on Adjuvant Abemaciclib Treatment with ER Loss at Metastatic Recurrence: A Case Report and Literature Review. Diagnostics. 2025; 15(23):3042.
https://doi.org/10.3390/diagnostics15233042
Chicago/Turabian Style
Sanò, Maria Vita, Lorenza Marino, Maria Puleo, Sarah Pafumi, Stefano Marletta, Giuseppina Rosaria Rita Ricciardi, and Carlo Carnaghi.
2025. "High-Risk Node-Positive Hormone Receptor-Positive/HER2-Low Breast Cancer Relapse on Adjuvant Abemaciclib Treatment with ER Loss at Metastatic Recurrence: A Case Report and Literature Review" Diagnostics 15, no. 23: 3042.
https://doi.org/10.3390/diagnostics15233042
APA Style
Sanò, M. V., Marino, L., Puleo, M., Pafumi, S., Marletta, S., Ricciardi, G. R. R., & Carnaghi, C.
(2025). High-Risk Node-Positive Hormone Receptor-Positive/HER2-Low Breast Cancer Relapse on Adjuvant Abemaciclib Treatment with ER Loss at Metastatic Recurrence: A Case Report and Literature Review. Diagnostics, 15(23), 3042.
https://doi.org/10.3390/diagnostics15233042
